Theriva Biologics Stock Forecast - 4 Period Moving Average

TOVX Stock  USD 1.34  0.06  4.69%   
The 4 Period Moving Average forecasted value of Theriva Biologics on the next trading day is expected to be 1.31 with a mean absolute deviation of 0.23 and the sum of the absolute errors of 13.12. Theriva Stock Forecast is based on your current time horizon.
  
At this time, Theriva Biologics' Payables Turnover is fairly stable compared to the past year. Fixed Asset Turnover is likely to rise to 5.85 in 2024, whereas Inventory Turnover is likely to drop (1.10) in 2024. . Common Stock Shares Outstanding is likely to rise to about 1.1 M in 2024, whereas Net Loss is likely to drop (23.8 M) in 2024.
A four-period moving average forecast model for Theriva Biologics is based on an artificially constructed daily price series in which the value for a given day is replaced by the mean of that value and the values for four preceding and succeeding time periods. This model is best suited to forecast equities with high volatility.

Theriva Biologics 4 Period Moving Average Price Forecast For the 29th of November

Given 90 days horizon, the 4 Period Moving Average forecasted value of Theriva Biologics on the next trading day is expected to be 1.31 with a mean absolute deviation of 0.23, mean absolute percentage error of 0.14, and the sum of the absolute errors of 13.12.
Please note that although there have been many attempts to predict Theriva Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Theriva Biologics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Theriva Biologics Stock Forecast Pattern

Backtest Theriva BiologicsTheriva Biologics Price PredictionBuy or Sell Advice 

Theriva Biologics Forecasted Value

In the context of forecasting Theriva Biologics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Theriva Biologics' downside and upside margins for the forecasting period are 0.01 and 13.65, respectively. We have considered Theriva Biologics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
1.34
1.31
Expected Value
13.65
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the 4 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Theriva Biologics stock data series using in forecasting. Note that when a statistical model is used to represent Theriva Biologics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria110.6371
BiasArithmetic mean of the errors 0.1123
MADMean absolute deviation0.2263
MAPEMean absolute percentage error0.1248
SAESum of the absolute errors13.1225
The four period moving average method has an advantage over other forecasting models in that it does smooth out peaks and troughs in a set of daily price observations of Theriva Biologics. However, it also has several disadvantages. In particular this model does not produce an actual prediction equation for Theriva Biologics and therefore, it cannot be a useful forecasting tool for medium or long range price predictions

Predictive Modules for Theriva Biologics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Theriva Biologics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Theriva Biologics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.071.3014.00
Details
Intrinsic
Valuation
LowRealHigh
0.112.1214.82
Details
2 Analysts
Consensus
LowTargetHigh
4.104.505.00
Details

Other Forecasting Options for Theriva Biologics

For every potential investor in Theriva, whether a beginner or expert, Theriva Biologics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Theriva Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Theriva. Basic forecasting techniques help filter out the noise by identifying Theriva Biologics' price trends.

View Theriva Biologics Related Equities

 Risk & Return  Correlation

Theriva Biologics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Theriva Biologics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Theriva Biologics' current price.

Theriva Biologics Market Strength Events

Market strength indicators help investors to evaluate how Theriva Biologics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Theriva Biologics shares will generate the highest return on investment. By undertsting and applying Theriva Biologics stock market strength indicators, traders can identify Theriva Biologics entry and exit signals to maximize returns.

Theriva Biologics Risk Indicators

The analysis of Theriva Biologics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Theriva Biologics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting theriva stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Theriva Stock Analysis

When running Theriva Biologics' price analysis, check to measure Theriva Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theriva Biologics is operating at the current time. Most of Theriva Biologics' value examination focuses on studying past and present price action to predict the probability of Theriva Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theriva Biologics' price. Additionally, you may evaluate how the addition of Theriva Biologics to your portfolios can decrease your overall portfolio volatility.